Par Pharmaceutical Companies has appointed Antonio Pera as chief commercial officer, leading the company’s newly-integrated sales and marketing division following the acquisition of JHP Pharmaceuticals.
Pera was most recent senior VP, commercial operations at JHP, and has more than 30 years’ experience in the pharma industry.
His positions prior to joining JHP include senior VP, supply chain management at AmerisourceBergen Corporation, and senior management positions at Fresenius Kabi Pharmaceuticals, Oakwood Laboratories and Bedford Laboratories.
“Tony has enjoyed a distinguished career in the pharmaceutical industry and we are very pleased to have him join the Par team,” said Paul Campanelli, CEO of Par Pharmaceutical Companies.